Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noah Federman

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Journal of Cellular Biochemistry|July 1, 2016
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug ScreeningTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Cancers|February 11, 2023
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue SarcomaErlinda Maria Gordon, Sant P Chawla, Walter Andree Tellez, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomasAnthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer|September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomasSteven G DuBois, Theodore W Laetsch, Noah Federman, et al.
Pediatric Blood & Cancer|June 7, 2023
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosisAaron R Weiss, Sarah Dry, Clara Maygar, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Journal of Cellular Biochemistry|July 1, 2016
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug ScreeningTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Cancers|February 11, 2023
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue SarcomaErlinda Maria Gordon, Sant P Chawla, Walter Andree Tellez, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomasAnthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer|September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomasSteven G DuBois, Theodore W Laetsch, Noah Federman, et al.
Pediatric Blood & Cancer|June 7, 2023
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosisAaron R Weiss, Sarah Dry, Clara Maygar, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Pageof 12